Markus Naumann

9.5k total citations · 1 hit paper
117 papers, 5.4k citations indexed

About

Markus Naumann is a scholar working on Neurology, Cellular and Molecular Neuroscience and Physiology. According to data from OpenAlex, Markus Naumann has authored 117 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 67 papers in Neurology, 28 papers in Cellular and Molecular Neuroscience and 24 papers in Physiology. Recurrent topics in Markus Naumann's work include Botulinum Toxin and Related Neurological Disorders (41 papers), Neurological disorders and treatments (35 papers) and Genetic Neurodegenerative Diseases (18 papers). Markus Naumann is often cited by papers focused on Botulinum Toxin and Related Neurological Disorders (41 papers), Neurological disorders and treatments (35 papers) and Genetic Neurodegenerative Diseases (18 papers). Markus Naumann collaborates with scholars based in Germany, United States and Netherlands. Markus Naumann's co-authors include Karlheinz Reiners, Joseph Jankovic, Georg Becker, Daniela Berg, Klaus V. Toyka, Frank Erbguth, Axel Schramm, L. Solymosi, Cynthia Comella and Joseph Claßen and has published in prestigious journals such as The Lancet, Nature Genetics and SHILAP Revista de lepidopterología.

In The Last Decade

Markus Naumann

110 papers receiving 5.2k citations

Hit Papers

Practice guideline update summary: Botulinum neurotoxin f... 2016 2026 2019 2022 2016 100 200 300 400

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Markus Naumann Germany 38 3.4k 1.4k 1.3k 636 589 117 5.4k
Karlheinz Reiners Germany 47 3.8k 1.1× 1.9k 1.4× 1.1k 0.8× 556 0.9× 1.1k 1.9× 153 6.9k
Takamichi Hattori Japan 53 5.2k 1.6× 3.0k 2.2× 1.0k 0.8× 1.2k 1.9× 582 1.0× 308 8.6k
Dirk Dressler Germany 46 5.3k 1.6× 2.2k 1.6× 1.0k 0.8× 236 0.4× 1.3k 2.3× 237 7.3k
Jean Pouget France 38 2.4k 0.7× 1.4k 1.0× 554 0.4× 286 0.4× 491 0.8× 189 5.2k
Jennifer Linn Germany 43 2.6k 0.8× 668 0.5× 510 0.4× 220 0.3× 541 0.9× 185 6.1k
Lucio Santoro Italy 45 3.5k 1.0× 2.9k 2.1× 1.1k 0.8× 205 0.3× 999 1.7× 254 7.0k
Jasper R. Daube United States 48 3.6k 1.1× 1.9k 1.4× 710 0.5× 305 0.5× 536 0.9× 154 6.8k
Svein Ivar Mellgren Norway 35 1.6k 0.5× 838 0.6× 1.7k 1.3× 691 1.1× 196 0.3× 107 4.7k
Anne Louise Oaklander United States 38 1.1k 0.3× 784 0.6× 2.0k 1.5× 221 0.3× 266 0.5× 106 4.9k
Cynthia Comella United States 39 5.3k 1.6× 2.7k 2.0× 755 0.6× 188 0.3× 170 0.3× 123 6.2k

Countries citing papers authored by Markus Naumann

Since Specialization
Citations

This map shows the geographic impact of Markus Naumann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Markus Naumann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Markus Naumann more than expected).

Fields of papers citing papers by Markus Naumann

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Markus Naumann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Markus Naumann. The network helps show where Markus Naumann may publish in the future.

Co-authorship network of co-authors of Markus Naumann

This figure shows the co-authorship network connecting the top 25 collaborators of Markus Naumann. A scholar is included among the top collaborators of Markus Naumann based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Markus Naumann. Markus Naumann is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Liao, Minqi, Siqi Zhang, Cheng He, et al.. (2025). Air pollution and stroke: Short-term exposure's varying effects on stroke subtypes. Ecotoxicology and Environmental Safety. 298. 118296–118296. 1 indexed citations
2.
Liao, Minqi, Siqi Zhang, Maximilian Schwarz, et al.. (2025). Short-term effects of ultrafine particles on stroke events: an assessment using four different exposure metrics. Environment International. 204. 109823–109823.
3.
Naumann, Markus, et al.. (2024). Complement inhibition in seropositive generalized myasthenia gravis as rescue therapy in impending and effective treatment in frequently recurring impending myasthenic crisis—a case series. Therapeutic Advances in Neurological Disorders. 17. 4233582449–4233582449. 3 indexed citations
5.
Müller, Katharina, Sonja Schönecker, Katharina Kamm, et al.. (2024). Diagnostic accuracy and confounders of vagus nerve ultrasound in amyotrophic lateral sclerosis—a single-center case series and pooled individual patient data meta-analysis. Journal of Neurology. 271(9). 6255–6263. 1 indexed citations
6.
Meisinger, Christa, Dennis Freuer, Timo Schmitz, et al.. (2023). Inflammation biomarkers in acute ischemic stroke according to different etiologies. European Journal of Neurology. 31(1). e16006–e16006. 13 indexed citations
7.
Jankovic, Joseph, Jean Carruthers, Markus Naumann, et al.. (2023). Neutralizing Antibody Formation with OnabotulinumtoxinA (BOTOX®) Treatment from Global Registration Studies across Multiple Indications: A Meta-Analysis. Toxins. 15(5). 342–342. 16 indexed citations
8.
Wohlrab, Johannes, Falk G. Bechara, Christoph Schick, & Markus Naumann. (2023). Hyperhidrosis: A Central Nervous Dysfunction of Sweat Secretion. Dermatology and Therapy. 13(2). 453–463. 13 indexed citations
9.
Lowe, Nicholas J., Markus Naumann, & Nina Eadie. (2023). Treatment of hyperhidrosis with Botox (onabotulinumtoxinA): Development, insights, and impact. Medicine. 102(S1). e32764–e32764. 9 indexed citations
10.
Meisinger, Christa, Jakob Linseisen, Michael Ertl, et al.. (2022). Associations between pre-stroke physical activity and physical quality of life three months after stroke in patients with mild disability. PLoS ONE. 17(6). e0266318–e0266318. 5 indexed citations
11.
Ertl, Michael, Christa Meisinger, Jakob Linseisen, et al.. (2020). Long-Term Outcomes in Patients with Stroke after in-Hospital Treatment—Study Protocol of the Prospective Stroke Cohort Augsburg (SCHANA Study). Medicina. 56(6). 280–280. 11 indexed citations
12.
Naumann, Markus, Alastair Carruthers, Jean Carruthers, et al.. (2010). Meta‐analysis of neutralizing antibody conversion with onabotulinumtoxinA (BOTOX®) across multiple indications. Movement Disorders. 25(13). 2211–2218. 109 indexed citations
13.
Brin, Mitchell F., et al.. (2008). Long‐term treatment with botulinum toxin type A in cervical dystonia has low immunogenicity by mouse protection assay. Movement Disorders. 23(10). 1353–1360. 149 indexed citations
14.
Jankovic, Joseph, et al.. (2004). Evidence-Based Review of Patient-Reported Outcomes With Botulinum Toxin Type A. Clinical Neuropharmacology. 27(5). 234–244. 24 indexed citations
15.
Wunderlich, Silke, Karlheinz Reiners, Thomas Gasser, & Markus Naumann. (2001). Cervical dystonia in monozygotic twins: Case report and review of the literature. Movement Disorders. 16(4). 714–718. 8 indexed citations
16.
Zimprich, Alexander, Monika Grabowski, Friedrich Asmus, et al.. (2001). Mutations in the gene encoding ɛ-sarcoglycan cause myoclonus–dystonia syndrome. Nature Genetics. 29(1). 66–69. 309 indexed citations
17.
Wissel, Jörg, et al.. (2000). Management of Spasticity Associated Pain with Botulinum Toxin A. Journal of Pain and Symptom Management. 20(1). 44–49. 138 indexed citations
18.
Naumann, Markus, et al.. (1998). Focal Hyperhidrosis. Archives of Dermatology. 134(3). 301–301. 182 indexed citations
19.
20.
Reichmann, Heinz, Berthold Schalke, Peter Seibel, Markus Naumann, & Klaus V. Toyka. (1995). Sarcoid myopathy and mitochondrial respiratory chain defects: clinicopathological, biochemical and molecular biological analyses. Neuromuscular Disorders. 5(4). 277–283. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026